Nuo Therapeutics Reports Q2 2026 Financial Results

What Happened

• Nuo Therapeutics, Inc. (AURX) filed a Form 8‑K on August 17, 2026 to report its results of operations and financial condition for the second quarter of 2026. The company furnished a press release with those quarterly results as Exhibit 99, which is incorporated by reference into the filing.

Key Details

• Filing date: August 17, 2026 (Form 8‑K, Item 2.02).
• Event reported: Second-quarter 2026 financial results announced in a press release.
• Exhibits included: Exhibit 99 — the August 17, 2026 press release; Exhibit 104 — Inline XBRL cover page.
• No other material items (e.g., officer changes, mergers, bankruptcies) were reported in this 8‑K.

Why It Matters

• The filing notifies investors that Nuo has publicly released its Q2 2026 earnings information; investors should read the press release (Exhibit 99) to see revenue, earnings (or loss), cash position, and any management commentary or guidance.
• Because this 8‑K is limited to the earnings release, it does not by itself indicate other corporate actions (like executive changes or transactions). Review the full Exhibit 99 for the specific financial figures and management discussion before making investment decisions.

Keywords: earnings, quarterly results, revenue, financial results, press release, 8‑K.